首页> 外文OA文献 >DNA-Encoded Fetal Liver Tyrosine Kinase 3 Ligand and Granulocyte Macrophage-Colony-Stimulating Factor Increase Dendritic Cell Recruitment to the Inoculation Site and Enhance Antigen-Specific CD4+ T Cell Responses Induced by DNA Vaccination of Outbred Animals
【2h】

DNA-Encoded Fetal Liver Tyrosine Kinase 3 Ligand and Granulocyte Macrophage-Colony-Stimulating Factor Increase Dendritic Cell Recruitment to the Inoculation Site and Enhance Antigen-Specific CD4+ T Cell Responses Induced by DNA Vaccination of Outbred Animals

机译:DNa编码的胎儿肝酪氨酸激酶3配体和粒细胞巨噬细胞集落刺激因子增加接种位点的树突细胞募集并增强远交动物DNa疫苗接种诱导的抗原特异性CD4 + T细胞应答

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DNA-based immunization is a contemporary strategy for developing vaccines to prevent infectious diseases in animals and humans. Translating the efficacy of DNA immunization demonstrated in murine models to the animal species that represent the actual populations to be protected remains a significant challenge. We tested two hypotheses directed at enhancing DNA vaccine efficacy in outbred animals. The first hypothesis, that DNA-encoding fetal liver tyrosine kinase 3 ligand (Flt3L) and GM-CSF increases dendritic cell (DC) recruitment to the immunization site, was tested by intradermal inoculation of calves with plasmid DNA encoding Flt3L and GM-CSF followed by quantitation of CD1(+) DC. Peak DC recruitment was detected at 10-15 days postinoculation and was significantly greater (p < 0.05) in calves in the treatment group as compared with control calves inoculated identically, but without Flt3L and GM-CSF. The second hypothesis, that DNA encoding Flt3L and GM-CSF enhances immunity to a DNA vector-expressed Ag, was tested by analyzing the CD4(+) T lymphocyte response to Anaplasma marginale major surface protein 1a (MSP1a). Calves immunized with DNA-expressing MSP1a developed strong CD4(+) T cell responses against A. marginale, MSP1a, and specific MHC class II DR-restricted MSP1a epitopes. Administration of DNA-encoding Flt3L and GM-CSF before MSP1a DNA vaccination significantly increased the population of Ag-specific effector/memory cells in PBMC and significantly enhanced MSP1a-specific CD4(+) T cell proliferation and IFN-gamma secretion as compared with MHC class II DR-matched calves vaccinated identically but without Flt3L and GM-CSF. These results support use of these growth factors in DNA vaccination and specifically indicate their applicability for vaccine testing in outbred animals.
机译:基于DNA的免疫是开发用于预防动物和人类传染病的疫苗的当代策略。将鼠类模型中证明的DNA免疫功效转化为代表实际受保护种群的动物物种仍然是一项重大挑战。我们测试了两个旨在提高近亲动物DNA疫苗功效的假说。第一个假设是,编码小牛的DNA编码胎儿肝酪氨酸激酶3配体(Flt3L)和GM-CSF会增加树突状细胞(DC)募集到免疫部位,然后通过对小牛皮内接种编码Flt3L和GM-CSF的质粒DNA进行测试通过定量CD1(+)DC。接种后10-15天检测到峰值DC募集,与相同接种但未接种Flt3L和GM-CSF的对照犊牛相比,治疗组的犊牛的DC募集明显更高(p <0.05)。第二个假设是,编码Flt3L和GM-CSF的DNA增强了对表达DNA载体表达的Ag的免疫力,这是通过分析CD4(+)T淋巴细胞对无形体主要表面蛋白1a(MSP1a)的反应来测试的。用表达DNA的MSP1a免疫的小牛对角缘曲霉,MSP1a和特定的MHC II类DR限制性MSP1a表位产生了较强的CD4(+)T细胞应答。与MHC相比,在MSP1a DNA疫苗接种之前施用编码DNA的Flt3L和GM-CSF显着增加了PBMC中Ag特异性效应子/记忆细胞的数量,并显着增强了MSP1a特异性CD4(+)T细胞增殖和IFN-γ分泌。 II类DR匹配小牛同样接种,但没有Flt3L和GM-CSF。这些结果支持了这些生长因子在DNA疫苗接种中的应用,并特别表明了它们在近亲动物疫苗测试中的适用性。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号